United Therapeutics CorporationEquity-NMS: UTHR
Equity-NMS: UTHR
$227.28
+0.45
(28 Feb)
Loading Chart
1D
1W
3M
1Y
5Y
Previous close
$227.28
Open
$227.28
Today’s high
$227.61
Today’s low
$224.23
52W low
$204.44
52W high
$261.54
1Y
-7.62%
5Y
12.46%
PE
10.84
EPS (TTM)
19.81
Shares O/S
47.06M
Market cap
10.7B
Insights
No insights found for this stock
Compare with other stock
Price
1D
PE
Market cap
About United Therapeutics Corporation

United Therapeutics Corporation is a pharmaceutical company. The Company markets and sells four commercial therapies in the United States to treat pulmonary arterial hypertension (PAH): Tyvaso (treprostinil) Inhalation Solution (Tyvaso), which includes the Tyvaso Inhalation System; Tyvaso DPI (treprostinil) Inhalation Powder (Tyvaso DPI); Remodulin (treprostinil) Injection (Remodulin); Orenitram (treprostinil) Extended-Release Tablets (Orenitram); and Adcirca (tadalafil) Tablets (Adcirca).

Tyvaso and Tyvaso DPI are also approved to treat pulmonary hypertension associated with interstitial lung disease (PH-ILD). It also markets and sells an oncology product, Unituxin (dinutuximab) Injection (Unituxin), which is approved for treatment of high-risk neuroblastoma, and the Remunity Pump for Remodulin (Remunity). Tyvaso DPI incorporates the dry powder formulation technology and Dreamboat inhalation device technology used in MannKinds Afrezza (insulin human) Inhalation Powder product. .


FAQs

Can I buy United Therapeutics Corporation shares in India?
How to buy United Therapeutics Corporation shares in India?
What is the share price of United Therapeutics Corporation?
What is the Market Capitalization of United Therapeutics Corporation?
What is the PE ratio of United Therapeutics Corporation?
Is United Therapeutics Corporation a good stock to buy?
In which sector / industry does United Therapeutics Corporation operate?